Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Triparanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 4/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triparanol SCHEMBL5488333 | 0.93 | EBP (0.86) | EBPSIGMAR1KMT2AMEN1LMNA | |
| SCHEMBL4310502 | 0.89 | EBP (0.81) | EBPSIGMAR1KMT2AMEN1LMNA | |
| SCHEMBL7753432 | 0.88 | SIGMAR1 (0.79) | EBPSIGMAR1KMT2AMEN1LMNA | |
| SCHEMBL2711651 | 0.84 | EBP (0.73) | EBPSIGMAR1KMT2AMEN1LMNA | |
| SCHEMBL10878286 | 0.84 | EBP (0.72) | EBPSIGMAR1KMT2AMEN1LMNA | |
| SCHEMBL16910242 | 0.82 | SIGMAR1 (0.69) | EBPSIGMAR1KMT2AMEN1LMNA | |
| SCHEMBL330094 | 0.80 | SIGMAR1 (0.67) | EBPSIGMAR1KMT2AMEN1NPSR1 | |
| SCHEMBL10358944 | 0.78 | EBP (0.62) | EBPSIGMAR1KMT2AMEN1NPSR1 | |
| SCHEMBL10878998 | 0.78 | EBP (0.63) | EBPSIGMAR1KMT2AMEN1LMNA | |
| SCHEMBL3420518 | 0.76 | EBP (0.64) | EBPSIGMAR1KMT2AHTTCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2437 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235403-A1 | DIFFERENTIATION OF PANCREATIC ISLET CELLS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-11-13 | — | — | WO | claimed |
| CN-119991089-A | Early warning analysis method, device, equipment and medium for intelligent service hot line work order | 中国联合网络通信集团有限公司 | 2025-05-13 | — | — | CN | claimed |
| WO-2025097070-A1 | ORAL DOSAGE FORM WITH CATIONICALLY CHARGEABLE HYDROGEL FOR DELIVERY OF ACTIVE AGENT | ENTREGA INC. (US) | 2025-05-08 | — | — | WO | claimed |
| CN-119677539-A | Combination therapy for modulating lipid production | 俄亥俄州创新基金会 | 2025-03-21 | — | — | CN | claimed |
| US-20250082672-A1 | METAL (HYDR) OXIDE COMPOSITE COMPRISING POORLY SOLUBLE DRUG, METHOD FOR MANUFACTURING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | CNPHARM CO., LTD. (KR) | 2025-03-13 | — | — | US | claimed |
| EP-4520339-A2 | METAL (HYDR)OXIDE COMPOSITE COMPRISING POORLY SOLUBLE DRUG, METHOD FOR MANUFACTURING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Webiotree Co., Ltd. (KR) | 2025-03-12 | — | — | EP | claimed |
| US-12215355-B2 | Stem cell derived islet differentiation | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-02-04 | — | — | US | claimed |
| EP-4489865-A2 | COMBINATION THERAPIES FOR MODULATION OF LIPID PRODUCTION | Ohio State Innovation Foundation (US) | 2025-01-15 | — | — | EP | claimed |
| US-20240358767-A1 | STEM CELL DIFFERENTIATION AND CHEMICAL COMPOUNDS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2024-10-31 | — | — | US | claimed |
| EP-4430163-A2 | STEM CELL DIFFERENTIATION AND CHEMICAL COMPOUNDS | Vertex Pharmaceuticals Incorporated (US) | 2024-09-18 | — | — | EP | claimed |
| EP-0764017-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMACEUTICALS, INC. (US) | 1997-03-26 | — | — | EP | claimed |
| US-5520938-A | Low cholesterol eggs and method of selecting same | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1996-05-28 | — | — | US | claimed |
| EP-0708591-A1 | LOW CHOLESTEROL EGGS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1996-05-01 | — | — | EP | claimed |
| WO-1995002321-A1 | LOW CHOLESTEROL EGGS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1995-01-26 | — | — | WO | claimed |
| WO-1994021230-A1 | METHOD AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION | CELLEGY PHARMACEUTICALS, INC. (US) | 1994-09-29 | — | — | WO | claimed |
| EP-0178862-B1 | ANTIESTROGEN THERAPY FOR SYMPTOMS OF ESTROGEN DEFICIENCY | BCM Technologies, INC. (US) | 1993-08-04 | — | — | EP | claimed |
| WO-1992016226-A1 | IL-1 INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1992-10-01 | — | — | WO | claimed |
| US-4894373-A | CLOMIPHEN, ISOMERS AND SALTS | BCM TECHNOLOGIES, INC. (US) | 1990-01-16 | — | — | US | claimed |
| US-4729999-A | MENOPAUSE, SIDE EFFECT PREVENTION | BCM TECHNOLOGIES (US) | 1988-03-08 | — | — | US | claimed |
| EP-0178862-A2 | Antiestrogen therapy for symptoms of estrogen deficiency | BCM Technologies, INC. (US) | 1986-04-23 | — | — | EP | claimed |